AMAZE
DEAD

Serial Number

88821077

Owner

LEO PHARMA A/S

Attorney

B. Brett Heavner

Filing Date

Mar 4, 2020

Add to watchlist:

No watchlists yet
View on USPTO

AMAZE Trademark

Serial Number: 88821077

AMAZE is a trademark filed by LEO PHARMA A/S on March 4, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

LEO PHARMA A/S (122 trademarks)

IDUSTRIPARKEN 55
BALLERUP DK-2750 , DK

Entity Type: 03

Trademark Details

Filing Date

March 4, 2020

Registration Date

Not Registered

Published for Opposition

September 15, 2020

Goods & Services

Scientific and medical research in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; Pharmaceutical and scientific research and development services, scientific research and testing of pharmaceuticals, all in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of scientific and pharmaceutical research and development services and scientific research in relation to skin diseases and treatment of the skin; testing of pharmaceuticals in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin

Providing online forums for users for the sharing and transmission of information and messages about skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin

Pharmaceutical and medical preparations for treatment of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and for treatment of the skin

Medical services in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical and pharmaceutical consultation services and health consultation services, all in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 12, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 12, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 29, 2022 EXRA
SOU EXTENSION 4 GRANTED
Oct 27, 2022 EX4G
SOU EXTENSION 4 FILED
Oct 27, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 27, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 28, 2022 EXRA
SOU EXTENSION 3 GRANTED
Apr 26, 2022 EX3G
SOU EXTENSION 3 FILED
Apr 26, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 26, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 19, 2021 EXRA
SOU EXTENSION 2 GRANTED
Oct 15, 2021 EX2G
SOU EXTENSION 2 FILED
Oct 15, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 15, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 8, 2021 EXRA
SOU EXTENSION 1 GRANTED
May 6, 2021 EX1G
SOU EXTENSION 1 FILED
May 6, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
May 6, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 10, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 15, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 15, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 13, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 31, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 31, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 31, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 30, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2020 NWOS
NEW APPLICATION ENTERED
Mar 7, 2020 NWAP